CEO Interview: Veyonda® Enhances Radiotherapy in Prostate Cancer Treatment – DARRT-1 Interim Results

Quick Links

Location

Noxopharm Limited
Suite 71
159 Ridgecrop Drive
Sydney - Castle Hill
NSW 2154
Telephone:
+ 61 2 9144 2223

ABN
50 608 966 123

Contact us

Email Shareholder enquiries:
info@noxopharm.com
Patient enquiries:
medical.information@noxopharm.com
My shareholding:
www.automicgroup.com.au

Follow Us